Industry Insight SystemAgent status
Agent operations

Research system, in motion.

See what the Agent is researching, how it is organized, where evidence is weak, and whether the current conclusions are good enough to publish.

RuntimereadyBuilt 2026-08-27T06:38:27.499Z
f6159a75dd15c4d46525f2fe061391b1e390a7a9
Live Agent map · derived state

What is happening now

Read top to bottom: current state, your action, the research journey, the method, then the execution system.

Current stateEvidence is expanding — publication is blocked

The working insight exists, but it cannot advance until the missing evidence clears the quality gate.

expand · insufficient-support, insufficient-independent-groups, insufficient-source-types, low-evidence-quality, stale-evidence, low-coverage, unresolved-critical-contradiction, overall-score-below-thresholdCurrent frontier: quality validation
Your action · stand byNo action needed now

Contribution evidence is reviewed by an isolated Agent Reviewer; no merge approval is waiting for you.

Human authority remains for: paid sources, method activation, credentials, policy changes, and irreversible actions.

What the Agent is doing nowRepair the insufficient-source-verification + unsupported-claim review failure

Re-verify the two proposed primary URLs and limit every source observation and derived claim to directly observed evidence.

REV-4HVHJPKV391CHPGZ55JDWT2E1N · revise · confidence 91
Next bounded taskCan the Austrian audit-office URL be directly retrieved and does it explicitly support every stated cost, delay, communications, and benefit figure?
Overall research processOne journey, one highlighted frontier

The quality gate is the current node. The Agent loops back for stronger evidence instead of forcing a conclusion forward.

01activeBuild evidence base17 sources · 16 signals
02provisionalForm the insight5 patterns · 4 insights
03current blockerPass quality gate8 gate · insufficient-support, insufficient-independent-groups, insufficient-source-types, low-evidence-quality, stale-evidence, low-coverage, unresolved-critical-contradiction, overall-score-below-threshold
04waitingPublish decisions0 opportunities · 0 actions

Canonical inventory · not completion %: 17 Source · 16 Signal · 5 Pattern · 1 Hypothesis · 4 Insight · 0 Implication · 0 Opportunity · 0 Action

Insight method in useHow evidence becomes a defensible conclusion
digital-energy-opportunity-1.0.0
01Read high-density sources firstPrioritize evidence that adds the most decision-useful information per unit of effort.
02Require buyer-side proofA vendor claim cannot pass the gate without independent operational or economic evidence.
03Compare within real boundariesKeep country, market, and network conditions visible before transferring a conclusion.
Active profile · MTH-VMZHAS5DX5X0JDR8XJSN8JFHKK
Execution systemWho does the work

Technical roles stay visible, but they no longer compete with the research status.

Insight Lead + Method ScoutSet direction; test method changes in shadow.
Harness plans bounded workCreates replaceable scopes and sessions.
Codex workers gather evidenceAppend isolated Contributions through tools.
Agent Reviewer challengesApproves exact bytes or creates revision work; only approval may merge.
Derived from the active Method Profile, canonical projection, source-learning state, and quality assessment. This page cannot change research state.
Current research state

Quality before confidence

No canonical research change was recorded on 2026-08-27; open evidence gaps and next work carry forward.

Quality verdict
expand

continue-research

Overall evidence score
30

Coverage 80 / 100

Research velocity
0

useful information units per hour

Open blockers

  • Country variance
    Tariffs, smart-meter coverage, procurement and DSO incentives differ materially.
  • Independent buyer economics
    No comparable public ROI and implementation-cycle dataset has been found.
  • Buyer reports show measurable benefits from ANM and flexible connections, yet Alliander says grid congestion will remain for at least 10 years despite record investment because la…
    Do not upgrade the opportunity thesis to high confidence until research separates digitally addressable decision delay from physical and regulatory queues by country and DSO.
  • The thesis ranks trusted grid-model and flexibility workflows as a leading wedge, yet independent and buyer-authored UK evidence shows comparable digital-grid mechanisms can be de…
    Do not strengthen the opportunity thesis without evidence that product-level deployment economics survive asset readiness, customer adoption, installer or commissioning capacity, platform reliability, market-rule, and physical-alternative controls.
  • DSOs disclose measurable capacity and connection outcomes and large digital-system budgets, yet modelled DSO NPV can remain negative and real flexible-contract adoption can materi…
    Do not activate a high-confidence product ROI thesis until payer-specific value, implementation cost, regulation, and counterfactual are joined for one bounded production deployment.

Next bounded work

  • resample: GOFLEX demonstration results and DSO cost-benefit evidence
  • Find three DSO-authored before/after cases
  • Map procurement and regulated business cases
Source learning

Density changes what the Agent reads next.

Raw readings and calibrated evaluations remain separate. Purchase reviews always stop at a human gate.

External candidates
1

1 recorded readings

Pending paid reviews
0

The Agent never purchases automatically.

Ranking-driven next task

resample · Read the highest-ranked candidate to address Need buyer-authored cases that isolate named software implementation cost, implementation time, and before-after operational metrics from wider ANM/flexibility programmes.

Success: Extract decision-relevant evidence and its implementation boundary with content identity.
Stop: Stop at the bounded source or effort limit; do not lower the evidence threshold.

SRC-01M0B000000000000000000001

Human review queue

  • No purchase review is pending.
Publication boundary

Read the evidence, not a confidence performance.

Open insight site →

The current opportunity thesis remains in expansion until the missing evidence gates pass. Unreviewed worker output is never published as canonical insight.

Question and coverage map

Where the evidence chain is thin.

Counts describe canonical entities, not model activity. Empty downstream stages remain visible instead of being filled with narrative.

sources
17
signals
16
patterns
5
hypotheses
1
insights
4
implications
0
opportunities
0
actions
0

Open research gaps

  • Need to connect a disclosed European ADMS or DERMS procurement to its final award, acceptance date, actual total cost, and post-production before-after metrics under one intervention boundary.
    Priority 96 · open
    GAP-VT1V8XHMWCKNESMX27RWMQ7BMB
  • Need non-UK counterexamples or confirmations for delayed or narrowed ADMS, DERMS, hosting-capacity, flexibility, and smart-meter-enabled workflow deployments with buyer or regulator evaluation.
    Priority 92 · open
    GAP-G4N7XV2KR9TC5QW8MZP3Y6AHBD
  • Need buyer-authored cases that isolate named software implementation cost, implementation time, and before-after operational metrics from wider ANM/flexibility programmes.
    Priority 90 · open
    GAP-01K20000000000000000000061
  • Need country-by-country comparison of whether flexible connections, curtailment compensation, and local flexibility activation are legally and commercially available to DSOs.
    Priority 80 · open
    GAP-01K20000000000000000000062

Competitor / product matrix

No canonical competitor or product entities yet. This view remains empty until reviewed evidence enters the graph.

Opportunity map

No opportunity has passed the graph contract; current work remains at gap and insight level.

Contradiction cards

Disagreement stays visible.

Contradictions are append-only positions, not defects to hide.

critical · unresolved

Buyer reports show measurable benefits from ANM and flexible connections, yet Alliander says grid congestion will remain for at least 10 years despite record investment because labour, procedure, space, material, and policy constraints limit expansion.

Do not upgrade the opportunity thesis to high confidence until research separates digitally addressable decision delay from physical and regulatory queues by country and DSO.

CON-01K20000000000000000000051
critical · unresolved

The thesis ranks trusted grid-model and flexibility workflows as a leading wedge, yet independent and buyer-authored UK evidence shows comparable digital-grid mechanisms can be delayed, narrowed, assumption-sensitive, and unable to isolate benefits from wider market, asset, and operating-model changes.

Do not strengthen the opportunity thesis without evidence that product-level deployment economics survive asset readiness, customer adoption, installer or commissioning capacity, platform reliability, market-rule, and physical-alternative controls.

CON-1RY7K9MZQH2V6X3DFA8CT5PWNB
critical · unresolved

DSOs disclose measurable capacity and connection outcomes and large digital-system budgets, yet modelled DSO NPV can remain negative and real flexible-contract adoption can materially miss target.

Do not activate a high-confidence product ROI thesis until payer-specific value, implementation cost, regulation, and counterfactual are joined for one bounded production deployment.

CON-B644JBNA0HFW5YA4S90BSW18XZ
Research trajectory

Why the direction changed.

2026-08-18T14:12:00Z

Comparable buyer economics and implementation transferability

Buyer-authored outcomes strengthen the workflow thesis, while the critical physical and regulatory contradiction still blocks activation.

Next: Which comparable European buyers disclose implementation cost, time-to-value, attributable software effect, and failure boundaries?

TRJ-01M0AJVWNRY8R2HNK39VQ5M1W5
Agent self-review history

Can the Agent reject weak work before spending model budget?

Derived from verified append-only attempt history. Replay is zero work; missing call evidence stays unknown.

Attempted candidates
6

0 incomplete

Zero-model rejection
100%

preflight failures stopped before reservation

Confirmed model calls
0

0 unknown crash-window calls

Canonical event delta
0

approved evidence only

Latest round · closed

Does this candidate add traceable, decision-relevant evidence?

  • preflight-rejected · duplicate-entity-id
    3 candidates · 2 high-density · 221 ms
    RTA-01M0HGMTA082XKW5VMPAEFNSNX · CTB-HNR2C8NZ6W7GR0YGXG4BJSRR2S

Next: new-evidence · Create corrected evidence before another Review attempt.

Round RND-01M0HGMTA0E613D4SQ7J4AJC0H · checkpoint e01ff684f4bf78202bf6151a29c30ae0012742c9
Method evolution · experiment rejected

Frozen SDID contribution triangulation

baseline retained

Measured diagnosis

Which evidence-triangulation method can separate software contribution from regulatory, organisational, and physical co-interventions while preserving country comparability?

Failure class: source · target: sourceStrategy

MOB-FXPY708Y3M0F422SNCZ0E6NNFA
Framework evidence
3

independent methodology sources

Frozen pairs
3

same task, input, and budget

Candidate quality delta
-7.82

promotion requires +3.00

Candidate safety flags
3

direct URL verification failures

Experiment decision

reject · quality improvement below threshold · candidate has safety regressions

Cost regression 0.0% · latency regression 5.4%. Recommendation did not mutate the registry.

EXP-AFHBNEMDKGKC5A1CFMYAGDZHT6

Cross-domain experiment history

  • continue-trial · ai-governance · quality -4.23
    EXP-1SD2BTB8SRGZ8BQKTNTS1FH7CB
  • reject · digital-energy · quality -7.82
    EXP-AFHBNEMDKGKC5A1CFMYAGDZHT6

Mechanism and boundary

Pre-specify a contribution story and rival co-intervention pathways, estimate the software-associated buyer-economics increment with synthetic difference-in-differences on a harmonized country panel, then challenge that estimate with pathway evidence and placebo checks.

  • All comparator countries or segments adopt at the same time, leaving no credible donor pool.
  • Software is always bundled with regulation, physical assets, or organisational redesign, so pathway-specific contribution cannot be separated.
  • Weighted pre-treatment fit fails, outcome definitions are not harmonized, or country market structures have unmeasured discontinuities.
  • Only vendor-authored economics evidence is available; independence remains unmet.
  • Sparse observations, changing accounting boundaries, or anticipatory behavior invalidate the panel design.

Active binding

MTH-VMZHAS5DX5X0JDR8XJSN8JFHKK

No profile promotion or activation has occurred.

MCO-JJ5SJ8MP56C68AQ2Q9WVYMR3NF